World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
77
Citations
20550
World Ranking
1827
National Ranking
72

Overview

Tanja D. de Gruijl is affiliated with Vrije Universiteit Amsterdam in the Netherlands. Their research primarily focuses on medicine and immunology and microbiology, with a significant body of work in oncology and related subfields.

The scientist has contributed extensively to the fields of oncology and immunology, with specific interests including cancer immunotherapy and biomarkers, CAR-T cell therapy research, immunotherapy and immune responses, immune cell function and interaction, T-cell and B-cell immunology, immune cells in cancer, and esophageal cancer research and treatment.

Frequent co-authors collaborating with Tanja D. de Gruijl include:

  • Hans van Vliet
  • Rieneke van de Ven
  • Marieke F. Fransen
  • Famke L. Schneiders
  • Roeland Lameris

Their work appears regularly in a range of scientific journals and publication venues. The most frequent venues include:

  • Journal for ImmunoTherapy of Cancer
  • Frontiers in Immunology
  • Cancers
  • Regular and Young Investigator Award Abstracts
  • Clinical & Experimental Immunology

Tanja D. de Gruijl's notable recent publications include:

  • High-Voltage Electrical Pulses in Oncology: Irreversible Electroporation, Electrochemotherapy, Gene Electrotransfer, Electrofusion, and Electroimmunotherapy, 2020, Radiology
  • Neoadjuvant Chemoradiotherapy Combined with Atezolizumab for Resectable Esophageal Adenocarcinoma: A Single-arm Phase II Feasibility Trial (PERFECT), 2021, Clinical Cancer Research
  • Gamma Delta T-Cell Based Cancer Immunotherapy: Past-Present-Future, 2022, Frontiers in Immunology
  • Priming the tumor immune microenvironment with chemo(radio)therapy: A systematic review across tumor types, 2020, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  • Pancreatic Cancer and Immunotherapy: A Clinical Overview, 2021, Cancers

Best Publications

  • Functional delivery of viral miRNAs via exosomes

    D. Michiel Pegtel;Katherine Cosmopoulos;David A. Thorley-Lawson;Monique A. J. van Eijndhoven

  • Langerin is a natural barrier to HIV-1 transmission by Langerhans cells.

    Lot de Witte;Alexey Nabatov;Marjorie Pion;Donna Fluitsma

  • Combined immunotherapy with granulocyte-macrophage colony-stimulating factor-transduced allogeneic prostate cancer cells and ipilimumab in patients with metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trial

    Alfons J M van den Eertwegh;Jurjen Versluis;H Pieter van den Berg;Saskia J A M Santegoets

  • Whole body PD-1 and PD-L1 positron emission tomography in patients with non-small-cell lung cancer

    A. N. Niemeijer;D. Leung;M. C. Huisman;I. Bahce

  • High-Voltage Electrical Pulses in Oncology: Irreversible Electroporation, Electrochemotherapy, Gene Electrotransfer, Electrofusion, and Electroimmunotherapy

    Bart Geboers;Hester J Scheffer;Philip M Graybill;Alette H Ruarus

  • Prognostic effect of different PD-L1 expression patterns in squamous cell carcinoma and adenocarcinoma of the cervix.

    A. Marijne Heeren;Simone Punt;Maaike C. G. Bleeker;Katja N. Gaarenstroom

  • CD40-targeted dendritic cell delivery of PLGA-nanoparticle vaccines induce potent anti-tumor responses.

    Rodney A. Rosalia;Luis J. Cruz;Suzanne van Duikeren;Angelino T. Tromp

  • Whole-cell cancer vaccination: from autologous to allogeneic tumor- and dendritic cell-based vaccines

    Tanja D. de Gruijl;Alfons J. M. van den Eertwegh;Herbert M. Pinedo;Rik J. Scheper

  • Prostanoids Play a Major Role in the Primary Tumor-Induced Inhibition of Dendritic Cell Differentiation

    Claudia C. Sombroek;Anita G. M. Stam;Allan J. Masterson;Sinéad M. Lougheed

  • Maturation of Dendritic Cells Accompanies High-Efficiency Gene Transfer by a CD40-Targeted Adenoviral Vector

    Bryan W. Tillman;Tanja D. De Gruijl;Sylvia A. Luykx-de Bakker;Rik J. Scheper

  • Monitoring regulatory T cells in clinical samples: consensus on an essential marker set and gating strategy for regulatory T cell analysis by flow cytometry.

    Saskia J. A. M. Santegoets;Eveline M. Dijkgraaf;Alessandra Battaglia;Philipp Beckhove

  • The Rise of Allogeneic Natural Killer Cells As a Platform for Cancer Immunotherapy: Recent Innovations and Future Developments.

    John P. Veluchamy;Nina Kok;Hans J. van der Vliet;Henk M. W. Verheul

  • Neoadjuvant systemic therapy in melanoma: recommendations of the International Neoadjuvant Melanoma Consortium

    Rodabe N. Amaria;Alexander M. Menzies;Alexander M. Menzies;Alexander M. Menzies;Elizabeth M. Burton;Richard A. Scolyer;Richard A. Scolyer

  • MUTZ-3, a human cell line model for the cytokine-induced differentiation of dendritic cells from CD34+ precursors

    Allan J Masterson;Claudia C Sombroek;Tanja D De Gruijl;Yvo M F Graus

  • Gamma Delta T-Cell Based Cancer Immunotherapy: Past-Present-Future

    Unknown

  • Melanoma-specific tumor-infiltrating lymphocytes but not circulating melanoma-specific T cells may predict survival in resected advanced-stage melanoma patients

    J. B. A. G. Haanen;A. Baars;R. Gomez;P. Weder

  • Glycan-modified liposomes boost CD4+ and CD8+ T-cell responses by targeting DC-SIGN on dendritic cells

    Wendy W.J. Unger;Astrid J. van Beelen;Sven C. Bruijns;Medha Joshi

  • Defining the critical hurdles in cancer immunotherapy

    Bernard A. Fox;Bernard A. Fox;Dolores J. Schendel;Lisa H. Butterfield;Steinar Aamdal

  • CD4(+)CD25hi regulatory T-cell frequency correlates with persistence of human papillomavirus type 16 and T helper cell responses in patients with cervical intraepithelial neoplasia.

    Johan W. Molling;Tanja D. de Gruijl;Judith Glim;Maria Moreno

  • Favorable outcome in clinically stage II melanoma patients is associated with the presence of activated tumor infiltrating T-lymphocytes and preserved MHC class I antigen expression.

    Inge S. van Houdt;Berbel J.R. Sluijter;Laura M. Moesbergen;Wim M. Vos

  • Sunitinib-Induced Myeloid Lineage Redistribution in Renal Cell Cancer Patients: CD1c + Dendritic Cell Frequency Predicts Progression-Free Survival

    Hester van Cruijsen;Astrid A.M. van der Veldt;Laura Vroling;Dinja Oosterhoff

Frequent Co-Authors

Rik J. Scheper
Rik J. Scheper Amsterdam University Medical Centers
Henk M.W. Verheul
Henk M.W. Verheul Radboud University
Ekaterina S. Jordanova
Ekaterina S. Jordanova Vrije Universiteit Amsterdam
Yvette van Kooyk
Yvette van Kooyk Vrije Universiteit Amsterdam
George L. Scheffer
George L. Scheffer VU University Medical Center
Susan Gibbs
Susan Gibbs Vrije Universiteit Amsterdam
David T. Curiel
David T. Curiel Washington University in St. Louis
Sybren L. Meijer
Sybren L. Meijer University of Amsterdam
Akseli Hemminki
Akseli Hemminki University of Helsinki
Gerrit Jansen
Gerrit Jansen Amsterdam UMC

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in pursuing Immunology in the USA, exploring complementary healthcare degrees can expand career opportunities. Nursing roles, particularly Licensed Practical Nurse (LPN) and Nurse Practitioner (NP) pathways, often intersect with immunology in clinical settings.

Students seeking accessible entry points may find value in programs recognized as the which lpn programs are easiest to get into. These options help build foundational skills quickly, opening doors to immunology-related patient care roles.

For advanced practice, identifying the easiest np programs to get into can streamline progression while maintaining quality education standards. These degrees prepare graduates for more specialized clinical responsibilities.

Specialization in mental health is a significant area of growth within healthcare. The best psychiatric mental health nurse practitioner programs online offer excellent clinical placement rates, ensuring practical experience to support immunology applications in psychiatric care.

Budget-conscious students can consider the cheapest psychiatric nurse practitioner programs, which provide cost-effective routes to certification without compromising educational quality.

Overall, exploring these related degrees can complement immunology studies and enhance healthcare career prospects.

Best Scientists Citing Tanja D. de Gruijl

Trending Scientists

Recently Published Articles